Welcome to Fresenius SE
Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.
The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
Latest News
17.07.2008
Fresenius Medical Care Reports Preliminary Second Quarter and First Six Months 2008 ResultsFresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis products and services, today announced preliminary results for the second quarter and the first six months of 2008. >>>
17.07.2008
Fresenius SE successfully executes offering of € 554 million mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical CareFresenius SE today successfully priced an issue of mandatory exchangeable bonds with an aggregate nominal amount of € 554.4 million. >>>
17.07.2008
Issuance of mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care AG & Co. KGaAThe Management Board of Fresenius SE resolved today, with the consent of the Supervisory Board, to issue mandatory exchangeable bonds with a nominal amount of up to € 600 million. >>>
17.07.2008
Strong financial results in the first half of 2008Fresenius provides an overview on the financial results of the first half of 2008. >>>
09.07.2008
Fresenius Medical Care Signs Agreements for Intravenous Iron ProductsFresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis products and services, today announced that it signed exclusive license agreements for the intravenous (IV) Iron products Venofer® (iron sucrose) and Ferinject® (ferric carboxymaltose) to treat iron deficiency anemia experienced by dialysis patients. >>>